Kyverna Therapeutics

Kyverna Therapeutics

Kyverna Therapeutics

Overview
Date Founded

2018

Headquarters

740 Heinz Avenue Berkeley, California, 94710, United States

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Biotechnology

Company Description

KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. Their therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.

Executives & Employees

Chief Executive Officer

Chief Medical Officer

Board of Directors

Co-Founder at Vida Ventures LLC

Managing Director at Westlake Village BioPartners

Interim Chief Medical Officer & Head of Development at Nektar Therapeutics

Venture Partner at Versant Venture Management LLC

Vice President of Medical Sciences at Amgen, Inc.

Chief Executive Officer at Kyverna Therapeutics

Paths to Kyverna Therapeutics
Potential Connections via
Relationship Science
You
Kyverna Therapeutics
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kyverna Therapeutics. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kyverna Therapeutics's profile does not indicate a business or promotional relationship of any kind between RelSci and Kyverna Therapeutics.